1. Home
  2. RSSS vs OKYO Comparison

RSSS vs OKYO Comparison

Compare RSSS & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Research Solutions Inc

RSSS

Research Solutions Inc

HOLD

Current Price

$2.51

Market Cap

93.7M

ML Signal

HOLD

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

HOLD

Current Price

$1.78

Market Cap

79.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RSSS
OKYO
Founded
2006
2007
Country
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.7M
79.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RSSS
OKYO
Price
$2.51
$1.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$5.00
$6.00
AVG Volume (30 Days)
68.3K
397.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.92
N/A
Revenue Next Year
$7.09
N/A
P/E Ratio
$21.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.32
$1.03
52 Week High
$4.12
$3.35

Technical Indicators

Market Signals
Indicator
RSSS
OKYO
Relative Strength Index (RSI) 33.64 41.05
Support Level $2.41 $1.55
Resistance Level $2.62 $2.23
Average True Range (ATR) 0.13 0.22
MACD -0.02 -0.03
Stochastic Oscillator 18.87 23.58

Price Performance

Historical Comparison
RSSS
OKYO

About RSSS Research Solutions Inc

Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from its cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Share on Social Networks: